ARTICLE | Management Tracks
Ashrafian to lead Sanofi’s R&D
Serial entrepreneur and VC joins pharma amid other changes to executive committee
August 31, 2023 5:27 PM UTC
The new EVP of R&D at Sanofi will be venture capitalist and serial entrepreneur Houman Ashrafian, who is joining the pharma from SV Health Investors. Ashrafian is stepping into the role vacated by John Reed, who left in February to become EVP and head of pharmaceuticals R&D at Johnson & Johnson.
Ashrafian has co-founded and served as chair at several SV Health-backed biotechs, including TRexBio Inc., Sitryx Therapeutics Ltd., Alchemab Therapeutics Ltd. and Mestag Therapeutics Ltd. In 2015-16, he was VP of experimental therapeutics at UCB S.A. (Euronext:UCB). He is also visiting professor of experimental therapeutics at the University of Oxford...